Circassia Pharmaceuticals Plc Ord 0.08P is listed on the London Stock Exchange trading with ticker code CIR.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £30,198m, with approximately 285m shares in issue. Over the last year, Circassia Pharmaceuticals Plc share price has been traded in a range of 203.85, hitting a high of 283.60, and a low of 79.75.
Circassia Pharmaceuticals Plc, officially known as Circassia Pharmaceuticals Plc Ord 0.08P was formed in May of 2006, making the company eleven years old. The company filed its latest accounts on 31st December 2014. Circassia Pharmaceuticals Plc currently has 11 directors, and has had 4 previous directors over the last 11 years. In the last set of accounts produced by Pricewaterhousecoopers Llp, the company showed 8.50 million paid in salaries to the 49 staff (average wage of 173 thousand), with the directors receiving an average 392 thousand each. In the accounts filed in 2014, the company paid 0 in dividends. These accounts also showed Circassia Pharmaceuticals Plc to have a net worth of 188.71 million, with 186.59 million held in cash.
Circassia Pharmaceuticals Plc is in the Medicine and Biotech Research sector.
|Fidelity China Special Situations Plc (FCSS.L)|
|Evraz Plc (EVR.L)|
|Vectura Group Plc (VEC.L)|
|Murray Income Trust Plc (MUT.L)|
|Marshalls Plc (MSLH.L)|
|Shares in Issue||285m|
|52 Week High||283.60|
|52 Week Low||79.75|